Article Per Year (5 Year)
p-Index From 2020 - 2025
0.408
P-Index
This Author published in this journals
All Journal Indonesian Journal of Cardiology Jurnal Ilmu Kedokteran dan Kesehatan
Tanto, Ines Vidal
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Pentingnya Deteksi Dini Kelainan Jantung Pada Penderita Hipertensi Melalui Pemeriksaan Ekokardiografi: Pembelajaran Dari Penyaringan Massa Nasruddin, Sigit Pratama Iustitia; Handayani, Riana; Mulia, Erwin; Masfufah, Indy; Ransun, Terrance; Chandrasatria, Rony Mario; Meriedlona, Nuka; Krisnawati, Dwi; Endamatriza, Gadih Ranti; Trisnawati, Niputu Alit; Yulistiawati, Novitri; Tanto, Ines Vidal; Iyos, Rekha Nova; Fattimah, Eliza Techa; Krisnandi, Charles; Nurhayati, Senja
Jurnal Ilmu Kedokteran dan Kesehatan Vol 11, No 9 (2024): Volume 11 Nomor 9
Publisher : Prodi Kedokteran Fakultas Kedokteran Universitas Malahayati

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33024/jikk.v11i9.17364

Abstract

Hipertensi merupakan penyebab utama penyakit kardiovaskular dan kematian dini di seluruh dunia. Perubahan patofisiologi jantung akibat hipertensi terjadi secara diam-diam tanpa menimbulkan gejala. Deteksi dini dalam bentuk skrining dapat membantu mengidentifikasi kelompok berisiko tinggi guna mengurangi morbiditas, mortalitas, dan biaya kesehatan. Penelitian ini bertujuan untuk mengevaluasi prevalensi perubahan ekokardiografi pada pasien hipertensi. Penelitian Cross-Sectional ini menggunakan data program skrining massal pada 21 Mei 2023, di Rumah Sakit Harapan Bunda, Lampung Tengah, Indonesia. Kriteria inklusi meliputi orang dewasa berusia ≥18 tahun yang sebelumnya sudah terdiagnosis hipertensi. Kriteria eksklusi mencakup subjek dengan riwayat kelainan ekokardiografi yang sudah terdeteksi sebelumnya. Dari 600 peserta, 388 subjek memenuhi kriteria inklusi/eksklusi. Dari keseluruhan subjek, 50% mengidap hipertensi stadium 1, 27% hipertensi stadium 2, dan 23% hipertensi stadium 3. Abnormalitas jantung ditemukan pada 56% subjek, dengan 98% pasien memiliki abnormalitas TAPSE, 83% memiliki kelainan katup, 78% memiliki RMWA, 45% memiliki abnormalitas dimensi ruang jantung, dan 13% pasien memiliki ejeksi fraksi <40%. Tingginya prevalensi kerusakan organ target jantung secara diam-diam menunjukkan nilai potensial skrining ekokardiografi dalam mengidentifikasi gangguan jantung pada pasien dengan riwayat hipertensi meskipun tanpa gejala.
Longitudinal Strain Assessment Of Myocardial Dysfunction In Covid-19 Patients: Correlating Clinical Symptoms And Laboratory Results At Admission And Four Months Post-Treatment Liastuti, Lies Dina; Tanto, Ines Vidal; Rachman, Aditya; Robot, Marselly Maria; Dwiputra1, Bambang; Ariani, Rina; Danny, Siska Suridanda; Taofan, Taofan; Sukmawan, Renan
Jurnal Kardiologi Indonesia Vol 45 No 1 (2024): January - March, 2024
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.1685

Abstract

Background: Myocardial dysfunction is increasingly recognized as a complication of COVID-19 infection, with implications for patient prognosis and long-term cardiovascular health. Longitudinal strain, measured via echocardiography, is a sensitive marker of myocardial function that may provide valuable insights into cardiac involvement in COVID-19 patients. This study aimed to assess myocardial dysfunction using longitudinal strain analysis in COVID-19 patients, correlating clinical symptoms and laboratory results at admission and four months post-treatment. Methods : This study compared clinical and laboratory parameters in COVID-19 patients post-recovery with and without myocardial dysfunction. Adult COVID-19 survivors were included if they were hospitalized and met certain criteria. Independent variables included clinical factors and laboratory factors at admission, while the dependent variable was myocardial dysfunction assessed through longitudinal strain of the left and right ventricles on speckle tracking echocardiography. The study was conducted at the Harapan Kita Heart and Blood Vessel Center (RSJPDHK - FKUI)/Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, Jakarta. Results: This study examined the cardiovascular health of 162 participants three months after getting infected with COVID-19. Those with comorbidities had the lowest LV GLS levels. Admission factors like obesity, SpO2, and PaO2 levels were linked to decreased LV GLS levels. These findings suggest that these admission factors may predict the progression of COVID-19 syndrome and its implications on cardiovascular health. Conclusion: COVID-19 patients with cardiovascular comorbidities have lower LV-GLS values. CAD status during admission affects LV GLS values 3-6 months after COVID-19 infection, indicating myocardial dysfunction. Basal lateral LV-GLS correlates with obesity status, SpO2, and PaO2 during admission. Closely monitor COVID-19 patients with cardiovascular comorbidities and recognize the implications of CAD status on myocardial function post-infection.
Co-Authors Aditya Rachman, Aditya Ariani, Rina Chandrasatria, Rony Mario Dwiputra1, Bambang Endamatriza, Gadih Ranti Erwin Mulia Fattimah, Eliza Techa Handayani, Riana Krisnandi, Charles KRISNAWATI, DWI Liastuti, Lies Dina Masfufah, Indy Meriedlona, Nuka Nasruddin, Sigit Pratama Iustitia Nurhayati, Senja Rekha Nova Iyos, Rekha Nova Renan Sukmawan Robot, Marselly Maria Siska Suridanda Danny Taofan, Taofan Terrance Ransun Trisnawati, Niputu Alit Yulistiawati, Novitri